Alessandro Riva – CEO, Ichnos Sciences

16.03.2021
Alessandro Riva, MD joined biotech Ichnos Sciences as its founding CEO in 2019, leaving behind a storied career in oncology R&D at Novartis and Gilead. In an exclusive interview, Riva outlines his motivations behind taking on this new challenge, how the company's approach to oncology treatment differs from  - and complements - those of its competitors, and his ambitions for the future of Ichnos.  
Joining Ichnos as CEO represented a once-in-a-lifetime opportunity to connect all the dots in my career from both a scientific and business perspective
Become a PharmaBoardroom Member for free to access this content
Join the 20,000+ pharmaceutical professionals who already subscribe to PharmaBoardroom
Register
Already a member? Sign In
Tags:
Switzerland, Global CEO, Ichnos, Strategy, Biotech, Oncology, Cell & Gene Therapy, European Biotech

Related Interviews

Bruno Delie – General Manager, Luye Pharma Switzerland

Luye Pharma is a China-headquartered fully integrated oncology and CNS specialist. Bruno Delie, general manager for Switzerland, discusses the organization’s ambitious European expansion plan, looking to establish affiliates in the…

Barbara Fritsche-Surchat – Managing Director, Servier Switzerland

Barbara Fritsche-Surchat outlines Servier’s historic commitment to Switzerland, how the French mid-cap’s global oncology pivot is translating into its Swiss operations, and comments on the evolution of pharma salesforces post-pandemic.…

Karin Blumer – Director Global Patient Engagement, Novartis Oncology

Karin Blumer, director of global patient engagement at Swiss giant Novartis, gives fascinating insights into the global patient advocacy landscape today and how Novartis interacts with it, the work being…

Related Articles

Global / Roche to Disentangle from Novartis, Ending Two Decades of Constraints

After 20 years, Novartis will no longer own one third of Roche’s shares after the two Swiss pharma giants agreed to a transaction worth USD 20.7 billion. While Roche touted…

Long Read / Swiss Biotech - Onwards & Upwards

This piece forms part of InFocus Biotechs to Watch Switzerland 2021, a deep dive into the Swiss biotech ecosystem and fundamentals, featuring data sets, feature articles, and profiles of some…

Europe / Top 5 Countries for Pharma Production

The Top Five countries in Europe for pharma production. All located in Western Europe, Switzerland punches well above its weight to take top spot. This data is taken from the 2021…

Latest Report

InFigures Asia-Pacific 2021

Related Content

Switzerland
Global CEO
Ichnos
Strategy
Biotech
Oncology
Cell & Gene Therapy